← Leaderboards
Ofer Levy
Boston Children'S Hospital
$33,284,977
Attributed
$33,284,977
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.8M · FY2014–23$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$33,284,977 · 3
By mechanism
N01$33,284,977 · 3
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Sallie R. Permar$59,901,483
- Benjamin Curtis Warf$3,052,917
- Abhaya V Kulkarni$3,790,221
- Garnett H Kelsoe$38,441,709
- Patricia Ellen Davenport$1,042,475
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesAdjuvantHuman DiseasePathogenNewborn InfantCellsIn VivoContractorAdultLeadElderlyPharmaceutical ChemistryAnimal ModelInfluenza Virus VaccineFormulationProgramsImmunogenicityVaccine AdjuvantVaccine CandidateAntigensSmall MoleculeIn VitroT-LymphocyteBase
Grant awards (19)
Small-molecule adjuvants testing pipeline (Influenza)$1,392,087
N01 · FY2023 · AI · contact PI
Small-molecule adjuvants testing pipeline (Influenza)$2,127,305
N01 · FY2022 · AI · contact PI
Adjuvant Development within the context of a vaccine to protect against B. pertussis for use in newborns.$1,986,305
N01 · FY2022 · AI · contact PI
Adjuvant Discovery for Vaccines against Influenza Virus$112,821
N01 · FY2022 · AI · contact PI
Small-molecule adjuvants testing pipeline (Influenza)$1,709,833
N01 · FY2021 · AI · contact PI
Adjuvant testing pipeline for recombinant SARS-CoV2 vaccines$257,000
N01 · FY2021 · AI · contact PI
Adjuvant Development within the context of a vaccine to protect against B. pertussis for use in newborns.$3,721,570
N01 · FY2020 · AI · contact PI
Small-molecule adjuvants testing pipeline$1,978,738
N01 · FY2020 · AI · contact PI
Adjuvant testing pipeline for recombinant SARS-CoV2 vaccines$1,790,282
N01 · FY2020 · AI · contact PI
Adjuvant Development Program: Leading to an Opioid Vaccine$2,289,273
N01 · FY2019 · AI · contact PI
Adjuvant Development within the context of a vaccine to protect against B. pertussis for use in newborns.$1,777,596
N01 · FY2019 · AI · contact PI
Small-molecule adjuvants to enhance the efficacy of flu vaccines in newborns and the elderly$1,722,927
N01 · FY2019 · AI · contact PI
Infant HIV Vaccination: B-cell Lineage Study$1,322,017
N01 · FY2019 · AI · contact PI
Adjuvant Development Program: Leading to an Opioid Vaccine$708,000
N01 · FY2019 · AI · contact PI
Adjuvant Discovery for Vaccines against Influenza Virus$2,730,922
N01 · FY2018 · AI · contact PI
Adjuvant Discovery for Vaccines against Influenza Virus$1,843,527
N01 · FY2017 · AI · contact PI
Adjuvant Discovery for Vaccines against Influenza Virus$1,914,549
N01 · FY2016 · AI · contact PI
Adjuvant Discovery for Vaccines against Influenza Virus$1,942,519
N01 · FY2015 · AI · contact PI
Adjuvant Discovery for Vaccines against Influenza Virus$1,957,706
N01 · FY2014 · AI · contact PI